Insights into onco-cardiology: atrial fibrillation in cancer
- PMID: 24361314
- DOI: 10.1016/j.jacc.2013.11.026
Insights into onco-cardiology: atrial fibrillation in cancer
Abstract
Atrial fibrillation (AF) has been found to occur with an increased frequency in patients with malignancies, particularly in those undergoing cancer surgery. The occurrence of AF in cancer may be related to comorbid states or a direct tumor effect or may represent a complication of cancer surgical or medical therapy, whereas inflammation may be a common denominator for both conditions. Treating AF in patients with malignancies is a challenge, especially in terms of antithrombotic therapy, because cancer may result in an increased risk of either thrombosis or hemorrhage and an unpredictable anticoagulation response, whereas thromboembolic risk prediction scores such as CHADS2 (Cardiac Failure, Hypertension, Age, Diabetes, and Stroke [doubled]) may not be applicable. The general lack of evidence imposes an individualized approach to the management of AF in those patients, although some general recommendations based on current guidelines in noncancer patients and the existing evidence in cancer patients, where available, may be outlined.
Keywords: antithrombotic therapy; atrial fibrillation; cancer; chemotherapy; warfarin.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation.J Am Coll Cardiol. 2004 Mar 17;43(6):929-35. doi: 10.1016/j.jacc.2003.11.028. J Am Coll Cardiol. 2004. PMID: 15028346 Review.
-
Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.J Cardiovasc Electrophysiol. 2012 Jul;23(7):708-13. doi: 10.1111/j.1540-8167.2011.02257.x. Epub 2012 Jan 23. J Cardiovasc Electrophysiol. 2012. PMID: 22268375
-
Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.Clin Ther. 2008 Sep;30(9):1726-36. doi: 10.1016/j.clinthera.2008.09.010. Clin Ther. 2008. PMID: 18840379
-
Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry).Am J Cardiol. 2010 Apr 15;105(8):1130-4. doi: 10.1016/j.amjcard.2009.11.047. Epub 2010 Feb 20. Am J Cardiol. 2010. PMID: 20381665 Clinical Trial.
-
Treatment of atrial fibrillation.Br Med Bull. 2008;88(1):75-94. doi: 10.1093/bmb/ldn046. Epub 2008 Dec 5. Br Med Bull. 2008. PMID: 19059992 Review.
Cited by
-
Are cardiovascular comorbidities always associated with a worse prognosis in patients with lung cancer?Front Cardiovasc Med. 2022 Sep 23;9:984951. doi: 10.3389/fcvm.2022.984951. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36211566 Free PMC article. Review.
-
Chemotherapy Related Cardiotoxicity Evaluation-A Contemporary Review with a Focus on Cardiac Imaging.J Clin Med. 2024 Jun 26;13(13):3714. doi: 10.3390/jcm13133714. J Clin Med. 2024. PMID: 38999280 Free PMC article. Review.
-
Predicting outcomes in patients with cancer and atrial fibrillation.Ther Adv Cardiovasc Dis. 2019 Jan-Dec;13:1753944719860676. doi: 10.1177/1753944719860676. Ther Adv Cardiovasc Dis. 2019. PMID: 31319783 Free PMC article.
-
Recent advances in cardio-oncology: a report from the 'Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019'.ESC Heart Fail. 2019 Dec;6(6):1140-1148. doi: 10.1002/ehf2.12551. Epub 2019 Dec 28. ESC Heart Fail. 2019. PMID: 31884717 Free PMC article.
-
Atrial Fibrillation and Stroke Risk in Patients With Cancer: A Primer for Oncologists.J Oncol Pract. 2019 Dec;15(12):641-650. doi: 10.1200/JOP.18.00592. J Oncol Pract. 2019. PMID: 31825754 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
